2015
DOI: 10.1007/s10545-015-9868-y
|View full text |Cite
|
Sign up to set email alerts
|

Erratum to: The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Data from the European registry of UCD show that highest frequency of liver disease is present in ASL and OTC deficiency among all UCD [13]. A recent study confirmed that neonatal histopathological changes in hepatic involvement of UCD are nonspecific, whereas older patients develop variable hepatic fibrosis and focal changes resembling glycogen storage disorder and cirrhosis [14].…”
Section: Discussionmentioning
confidence: 99%
“…Data from the European registry of UCD show that highest frequency of liver disease is present in ASL and OTC deficiency among all UCD [13]. A recent study confirmed that neonatal histopathological changes in hepatic involvement of UCD are nonspecific, whereas older patients develop variable hepatic fibrosis and focal changes resembling glycogen storage disorder and cirrhosis [14].…”
Section: Discussionmentioning
confidence: 99%
“…1 Neurological complications include acute encephalopathic crises, stroke-like episodes, developmental delay, intellectual disability, psychiatric disease, motor dysfunction, epilepsy, and optic neuropathy. 1,2,[4][5][6] Basal ganglia, the brain region with higher metabolic and energy demands, are particularly vulnerable and are characteristically involved in patients with methylmalonic aciduria. 2 Progressive neurological damage may also develop in the form of cerebral or cerebellar atrophy and white matter disease, with or without basal ganglia lesions.…”
Section: Introductionmentioning
confidence: 99%
“…However, the standard therapeutic strategies, which rely on dietary natural protein restriction supplemented with non‐offending amino acids mixtures, carnitine therapy, and intensified emergency regimens during catabolic episodes, are only partially effective in preventing neurological disease progression and selective organ damage 1 . Neurological complications include acute encephalopathic crises, stroke‐like episodes, developmental delay, intellectual disability, psychiatric disease, motor dysfunction, epilepsy, and optic neuropathy 1,2,4–6 . Basal ganglia, the brain region with higher metabolic and energy demands, are particularly vulnerable and are characteristically involved in patients with methylmalonic aciduria 2 .…”
Section: Introductionmentioning
confidence: 99%